Cite
Edaravone inhibits procaspase‐3 denitrosylation and activation through FasL‐Trx2 pathway in KA‐induced seizure.
MLA
Hao, Lingyun, et al. “Edaravone Inhibits Procaspase‐3 Denitrosylation and Activation through FasL‐Trx2 Pathway in KA‐induced Seizure.” Fundamental & Clinical Pharmacology, vol. 34, no. 6, Dec. 2020, pp. 662–70. EBSCOhost, https://doi.org/10.1111/fcp.12556.
APA
Hao, L., Dong, L., Yu, Q., Shen, W., & Wei, X. (2020). Edaravone inhibits procaspase‐3 denitrosylation and activation through FasL‐Trx2 pathway in KA‐induced seizure. Fundamental & Clinical Pharmacology, 34(6), 662–670. https://doi.org/10.1111/fcp.12556
Chicago
Hao, Lingyun, Ling Dong, Qiuxing Yu, Wen Shen, and Xuewen Wei. 2020. “Edaravone Inhibits Procaspase‐3 Denitrosylation and Activation through FasL‐Trx2 Pathway in KA‐induced Seizure.” Fundamental & Clinical Pharmacology 34 (6): 662–70. doi:10.1111/fcp.12556.